Skip to main content

Table 2 Demographic characteristics, scanner dose and apnea duration in FDCT and LDCT groups

From: Submillisievert CT chest for COVID-19 patients in a rural hospital with limited resources

 

FDCT

LDCT

P value

Total examinations

269

194

 

Period

April–Dec 2020

Dec 2020–March 2021

 

Age

  

P = 0.8729a

Median (IQR)

55 (30)

56 (20)

 

[min–max]

[14–92]

[20–96]

 

Sex

  

P = 0.0357b

Male

126 (46.8%)

110 (56.7%)

 

Female

143 (53.2%)

84 (43.3%)

 

Weight

  

P = 0.2501a

Mean (SD)

85 (15)

79 (14)

 

[min–max]

[60–112]

[59–110]

 

DLP (mGy*cm)

  

P < 0.0001a

Median (IQR)

341.1 [204.1]

30.8 (3.9)

 

[min–max]

[72.6–975.6]

[8.4–71.1]

 

CTDI

  

P < 0.0001a

Median (IQR)

11.3 (5.5)

0.9 (0)

 

[min–max]

[0.4–29.8]

[0.3–2.6]

 

Duration of apnea

  

P < 0.0001a

Median (IQR)

13.29 (4.9)

8.27 (1.2)

 

[min–max]

[7.02–37.26]

[6.71–15.78]

 
  1. DLP, Dose length product; CTDI, CT dose index
  2. aTwo-tailed Mann–Whitney U test
  3. bFisher Exact test